​

Harvard Bioscience (HBIO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HBIO Stock Forecast

Harvard Bioscience (HBIO) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 1.52% increase from the last price of $5.91.

High: $6 Avg: $6 Low: $6 Last Closed Price: $5.91

HBIO Stock Rating

Harvard Bioscience stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (80.00%), 1 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 4 Strong Sell Sell Hold Buy Strong Buy

HBIO Price Target Upside V Benchmarks

TypeNameUpside
StockHarvard Bioscience1.52%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks20.92%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$6.00$6.00
Last Closing Price$5.91$5.91$5.91
Upside/Downside-1.52%1.52%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 261-1--2
Mar, 26-11--2
Feb, 26-11--2
Jan, 26-11--2
Dec, 25-11--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 13, 2026New Street$0.60$0.4922.45%-89.85%
Aug 08, 2024Paul KnightKeyBanc$7.00$3.12124.36%18.44%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 13, 2026BenchmarkSpeculative BuySpeculative Buyhold
Sep 10, 2025BenchmarkSpeculative BuySpeculative Buyhold
Aug 09, 2024BenchmarkSpeculative BuySpeculative Buyhold
Aug 08, 2024KeyBancOverweightOverweighthold
Mar 10, 2023BenchmarkBuyupgrade

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.01$-0.23$-0.08$-0.28$-1.28-
Avg Forecast$0.28$0.09$0.16$0.05$0.13$0.25
High Forecast$0.30$0.09$0.16$0.05$0.18$0.25
Low Forecast$0.28$0.09$0.16$0.04$0.07$0.25
Surprise %-103.57%-355.56%-150.00%-660.00%-1084.62%-

Revenue Forecast

$85M $93M $101M $109M $117M $125M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$118.90M$113.33M$112.25M$94.14M$86.55M-
Avg Forecast$118.33M$115.23M$113.17M$93.75M$97.80M$112.00M
High Forecast$122.08M$116.06M$113.65M$94.15M$98.22M$112.48M
Low Forecast$115.97M$114.40M$112.68M$93.35M$97.38M$111.52M
Surprise %0.49%-1.65%-0.81%0.41%-11.50%-

Net Income Forecast

$-60M $-45M $-30M $-15M $0 $15M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-288.00K$-9.52M$-3.42M$-12.40M$-56.70M-
Avg Forecast$12.02M$-4.93M$-3.42M$1.91M$5.30M$10.61M
High Forecast$12.51M$-2.54M$-1.76M$1.92M$7.64M$10.66M
Low Forecast$11.71M$-7.32M$-5.07M$1.90M$2.97M$10.55M
Surprise %-102.40%93.02%--749.85%-1169.31%-

HBIO Forecast FAQ

Is Harvard Bioscience stock a buy?

Harvard Bioscience stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Harvard Bioscience is a favorable investment for most analysts.

What is Harvard Bioscience's price target?

Harvard Bioscience's price target, set by 5 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 1.52% change from the previous closing price of $5.91.

How does Harvard Bioscience stock forecast compare to its benchmarks?

Harvard Bioscience's stock forecast shows a 1.52% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical instruments & supplies stocks industry (20.92%).

What is the breakdown of analyst ratings for Harvard Bioscience over the past three months?

  • April 2026: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Harvard Bioscience’s EPS forecast?

Harvard Bioscience's average annual EPS forecast for its fiscal year ending in December 2026 is $0.25, marking a -119.53% decrease from the reported $-1.28 in 2025..

What is Harvard Bioscience’s revenue forecast?

Harvard Bioscience's average annual revenue forecast for its fiscal year ending in December 2026 is $112M, reflecting a 29.40% increase from the reported $86.55M in 2025.

What is Harvard Bioscience’s net income forecast?

Harvard Bioscience's net income forecast for the fiscal year ending in December 2026 stands at $10.6M, representing a -118.70% decrease from the reported $-56.7M in 2025.